Romiplostim more effective than standard care for immune thrombocytopenia
A new study finds that an FDA-approved drug to treat the rare autoimmune disorder immune thromobocytopenia (ITP) is more effective than earlier medical therapies in helping patients avoid surgical treatment and significantly ...
Nov 10, 2010
not rated yet
0
